BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
74 results:

  • 1. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
    PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparative Analysis of the Prognostic Significance of IDH,TERT, EGFR and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study.
    Alimohamadi M; Larijani A; Pour-Rashidi A; Farzin M; Ebrahimi H; Rahmani M; Hendi K; Yarandi KK; Aghajanian S; Shirani M
    World Neurosurg; 2024 Jan; 181():e628-e639. PubMed ID: 37914076
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.
    Wu F; Yin YY; Fan WH; Zhai Y; Yu MC; Wang D; Pan CQ; Zhao Z; Li GZ; Zhang W
    EBioMedicine; 2023 Jan; 87():104410. PubMed ID: 36525723
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy.
    Liang X; Wang Z; Dai Z; Zhang H; Zhang J; Luo P; Liu Z; Liu Z; Yang K; Cheng Q; Zhang M
    Cancer Gene Ther; 2023 Mar; 30(3):481-496. PubMed ID: 36494582
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development and Validation of a Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Low-Grade Gliomas.
    Ning L; Zhao G; Xie C; Lan H; Chen J; Tan H; Wei C; Zhou Z
    Dis Markers; 2022; 2022():1487165. PubMed ID: 36193491
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas.
    Goschzik T; Mynarek M; Doerner E; Schenk A; Spier I; Warmuth-Metz M; Bison B; Obrecht D; Struve N; Kortmann RD; Schmid M; Aretz S; Rutkowski S; Pietsch T
    Acta Neuropathol; 2022 Dec; 144(6):1143-1156. PubMed ID: 36181537
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
    Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
    BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Can a signature molecular-profile define disparate survival in BRAF-positive Gliosarcoma and identify novel targets for therapeutic intervention?
    Gandhi P; Khare R; Garg N; Mishra J
    J Cancer Res Ther; 2022; 18(1):224-230. PubMed ID: 35381788
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli.
    Zhang Y; Liu X; Li A; Tang X
    PLoS One; 2022; 17(3):e0265655. PubMed ID: 35303016
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma.
    Zhou Q; Yan X; Zhu H; Xin Z; Zhao J; Shen W; Yin W; Guo Y; Xu H; Zhao M; Liu W; Jiang X; Ren C
    Theranostics; 2021; 11(20):9775-9790. PubMed ID: 34815785
    [No Abstract]    [Full Text] [Related]  

  • 12. apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide.
    Ding Y; Zhang C; He L; Song X; Zheng C; Pan Y; Yu S
    Bioengineered; 2021 Dec; 12(2):10791-10798. PubMed ID: 34753395
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preclinical Evaluation of Sodium Selenite in Mice: Toxicological and Tumor Regression Studies after Striatum Implantation of Human Glioblastoma Stem Cells.
    Larrouquère L; Berthier S; Chovelon B; Garrel C; Vacchina V; Paucot H; Boutonnat J; Faure P; Hazane-Puch F
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638987
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Phospholipase Cγ1 represses colorectal cancer growth by inhibiting the Wnt/β-catenin signaling axis.
    Shin KJ; Jang HJ; Lee YJ; Lee YG; Suh PG; Yang YR; Chae YC
    Biochem Biophys Res Commun; 2021 Nov; 577():103-109. PubMed ID: 34509721
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sp1-Induced FNBP1 Drives Rigorous 3D Cell Motility in EMT-Type Gastric cancer Cells.
    Yoon BK; Hwang N; Chun KH; Lee Y; Duarte TPM; Kim JW; Kim TH; Cheong JH; Fang S; Kim JW
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202606
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Gliosarcoma with PNET features mimicking a metastatic neuroendocrine carcinoma: A diagnostic dilemma.
    McGahan BG; Toop N; Ward S; Jones D; Kobalka PJ; Palmer JD; Elder JB
    Clin Neuropathol; 2021; 40(5):279-285. PubMed ID: 34190681
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long non‑coding RNA NEAT1 regulates glioma cell proliferation and apoptosis by competitively binding to microRNA‑324‑5p and upregulating KCTD20 expression.
    Zhang J; Li Y; Liu Y; Xu G; Hei Y; Lu X; Liu W
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982764
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Effect of rebiopsy methods and clinical features on T790M mutation after first-line EGFR-TKI treatment failure.
    Zhou J; Li Y; Zhang Y; Dai H; Guo S
    Future Oncol; 2021 Jul; 17(19):2475-2488. PubMed ID: 33769072
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Medulloblastoma and familial adenomatous polyposis: Good prognosis and good quality of life in the long-term?
    Massimino M; Signoroni S; Boschetti L; Chiapparini L; Erbetta A; Biassoni V; Schiavello E; Ferrari A; Spreafico F; Terenziani M; Chiaravalli S; Puma N; Bergamaschi L; Ricci MT; Cattaneo L; Gattuso G; Buttarelli FR; Gianno F; Miele E; Poggi G; Vitellaro M
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28912. PubMed ID: 33459525
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
    Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
    Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.